<?xml version='1.0'?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:atom="http://www.w3.org/2005/Atom" >
<channel>
	<title><![CDATA[BOL: Drawback of Exome Sequencing]]></title>
	<link>https://bioinformaticsonline.com/news/view/11365/drawback-of-exome-sequencing?</link>
	<atom:link href="https://bioinformaticsonline.com/news/view/11365/drawback-of-exome-sequencing?" rel="self" type="application/rss+xml" />
	<description><![CDATA[]]></description>
	
	<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/11365/drawback-of-exome-sequencing</guid>
	<pubDate>Mon, 02 Jun 2014 05:46:43 -0500</pubDate>
	<link>https://bioinformaticsonline.com/news/view/11365/drawback-of-exome-sequencing</link>
	<title><![CDATA[Drawback of Exome Sequencing]]></title>
	<description><![CDATA[<p><span><span>Dr Eric Londin, Assistant Professor, Thomas Jefferson University, USA, stated that analysis of 44 exome datasets from four different testing kits showed that they missed a high proportion of clinically relevant regions in the 56 ACMG genes. "At least one gene in each exome method was missing more than 40 percent of disease-causing genetic variants, and we found that the worst-performing method missed more than 90 percent of such variants in four of the 56 genes," he says.</span><br /></span></p><p><span><strong>Source</strong>:&nbsp;http://www.eurekalert.org/pub_releases/2014-05/esoh-pco052914.php</span></p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
</item>

</channel>
</rss>